Navigation Links
HeartWare to Webcast Annual Meeting
Date:7/29/2009

FRAMINGHAM, Mass. and SYDNEY, July 29 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR, ASX: HIN) today announced that its Annual Meeting will be held at The Westin Sydney, 1 Martin Place, Sydney at 7:00 pm US Eastern today, July 29 (9:00 am Sydney time on July 30, 2009).

The Annual Meeting will be webcast and may be viewed at the Company's website (www.heartware.com) by selecting "HeartWare International Annual General Meeting - Webcast" under the section titled Corporate Presentations (on the HOME page).

About HeartWare International, Inc.

HeartWare International, Inc. develops and manufactures miniaturized implantable heart pumps, or Left Ventricular Assist Devices (LVADs), to treat patients suffering from advanced heart failure. The HeartWare((R)) Ventricular Assist System features the HVAD((TM)) pump, the only full-output pump designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. HeartWare has completed an international clinical trial for the device involving five investigational centres in Europe and Australia. The device is currently the subject of a 150-patient clinical trial in the United States for a Bridge-to-Transplant indication.

    For further information:
    US Investor Relations
    Matt Clawson
    Partner
    Allen & Caron Inc
    Email: matt@allencaron.com
    Tel: +1 949 474 4300


'/>"/>
SOURCE HeartWare International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. HeartWare to Present at Eighth Annual JMP Securities Research Conference
2. Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission
3. Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;
4. HeartWare to Present at Seventh Annual JMP Securities Research Conference
5. HeartWare Receives Conditional Approval of IDE
6. HeartWare Announces Move to an Expanded, Upgraded Manufacturing Facility
7. HeartWare Selects Allen & Caron for Investor Relations and Corporate Communications
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, August 3, 2009
9. Medivation Announces Second Quarter 2009 Financial Results Teleconference and Webcast on August 5, 2009
10. FRC Action to Host Webcast Tonight on the Government Takeover of Health Care
11. FRC Action to Host Webcast on the Government Takeover of Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... OMI Industries, a worldwide ... a distribution partnership with Byers Scientific & Manufacturing , a leading designer, ... the agreement, OMI Industries formulated a special version of Ecosorb® for Byers Scientific ...
(Date:1/24/2017)... ... January 24, 2017 , ... Center for Hispanic Leadership ... has named Hector M. Chavez, Manager, Employee & Labor Relations at City of ... its Hispanic Leader of the Month. City of Hope is committed to stay out ...
(Date:1/24/2017)... City, IA (PRWEB) , ... January 24, 2017 , ... ... the country, has taken great care to design a program that provides teachers with ... abroad and domestically. This online teaching certificate is ideal for post-baccalaureate students and HigherEducation.com ...
(Date:1/24/2017)... ... 2017 , ... The NewKILO JRP, a three-year project of the European Metrology ... Union (EU), was completed in May 2015. The future definition will require the unit ... air, which presents some challenges to establishing traceability to the mass scale. , This ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... ... water, has officially unveiled its latest award-winning bottles, designed specifically to optimize the ... , Taza Agua is renowned for introducing the world’s first untouched bottled ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... New York , January 24, 2017 ... three players held a whopping share of 91.6% in ... Technology, IMA Pharma, and Qualipcaps have been leading the ... leaders boast an experience and expertise in handling sophisticated ... companies are expected to focus on research and development ...
(Date:1/24/2017)... , Jan. 24, 2017   QR ... biopharmaceutical company developing novel therapies for the treatment ... announced the appointment of four world-class key opinion ... new appointments join QR Pharma,s previous roster of ... and direction to support the development of the ...
(Date:1/24/2017)... January 24, 2017 The global  ... USD 3.8 billion by 2025, according to a new ... can be attributed to the rising initiatives by various ... of micro calcifications in breast tissue. Some significant organizations ... Breast Cancer Organization are promoting the early diagnosis of ...
Breaking Medicine Technology: